Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades

NCT02245165 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Motility Disorder
Disturbance of Salivary Secretion

Interventions

BIOLOGICAL: L-Nitro-Monomethyl-Arginine (LNMMA) 10 mg/kg IV
BIOLOGICAL: saline

Sponsor

Uppsala University

Collaborators

[object Object]
[object Object]